Corrigendum to “Quercitrin loaded cyclodextrin based nanosponge as a promising approach for management of lung cancer and COVID-19” [J. Drug Deliv. Sci. Technol. 77 (2022) 103921]

Detalles Bibliográficos
Autores principales: Taleb, Sally Abou, Moatasim, Yassmin, GabAllah, Mohamed, Asfour, Marwa Hasanein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202194/
https://www.ncbi.nlm.nih.gov/pubmed/37303498
http://dx.doi.org/10.1016/j.jddst.2023.104576
_version_ 1785045390139064320
author Taleb, Sally Abou
Moatasim, Yassmin
GabAllah, Mohamed
Asfour, Marwa Hasanein
author_facet Taleb, Sally Abou
Moatasim, Yassmin
GabAllah, Mohamed
Asfour, Marwa Hasanein
author_sort Taleb, Sally Abou
collection PubMed
description
format Online
Article
Text
id pubmed-10202194
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-102021942023-05-23 Corrigendum to “Quercitrin loaded cyclodextrin based nanosponge as a promising approach for management of lung cancer and COVID-19” [J. Drug Deliv. Sci. Technol. 77 (2022) 103921] Taleb, Sally Abou Moatasim, Yassmin GabAllah, Mohamed Asfour, Marwa Hasanein J Drug Deliv Sci Technol Article Elsevier B.V. 2023-08 2023-05-22 /pmc/articles/PMC10202194/ /pubmed/37303498 http://dx.doi.org/10.1016/j.jddst.2023.104576 Text en © 2023 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Taleb, Sally Abou
Moatasim, Yassmin
GabAllah, Mohamed
Asfour, Marwa Hasanein
Corrigendum to “Quercitrin loaded cyclodextrin based nanosponge as a promising approach for management of lung cancer and COVID-19” [J. Drug Deliv. Sci. Technol. 77 (2022) 103921]
title Corrigendum to “Quercitrin loaded cyclodextrin based nanosponge as a promising approach for management of lung cancer and COVID-19” [J. Drug Deliv. Sci. Technol. 77 (2022) 103921]
title_full Corrigendum to “Quercitrin loaded cyclodextrin based nanosponge as a promising approach for management of lung cancer and COVID-19” [J. Drug Deliv. Sci. Technol. 77 (2022) 103921]
title_fullStr Corrigendum to “Quercitrin loaded cyclodextrin based nanosponge as a promising approach for management of lung cancer and COVID-19” [J. Drug Deliv. Sci. Technol. 77 (2022) 103921]
title_full_unstemmed Corrigendum to “Quercitrin loaded cyclodextrin based nanosponge as a promising approach for management of lung cancer and COVID-19” [J. Drug Deliv. Sci. Technol. 77 (2022) 103921]
title_short Corrigendum to “Quercitrin loaded cyclodextrin based nanosponge as a promising approach for management of lung cancer and COVID-19” [J. Drug Deliv. Sci. Technol. 77 (2022) 103921]
title_sort corrigendum to “quercitrin loaded cyclodextrin based nanosponge as a promising approach for management of lung cancer and covid-19” [j. drug deliv. sci. technol. 77 (2022) 103921]
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202194/
https://www.ncbi.nlm.nih.gov/pubmed/37303498
http://dx.doi.org/10.1016/j.jddst.2023.104576
work_keys_str_mv AT talebsallyabou corrigendumtoquercitrinloadedcyclodextrinbasednanospongeasapromisingapproachformanagementoflungcancerandcovid19jdrugdelivscitechnol772022103921
AT moatasimyassmin corrigendumtoquercitrinloadedcyclodextrinbasednanospongeasapromisingapproachformanagementoflungcancerandcovid19jdrugdelivscitechnol772022103921
AT gaballahmohamed corrigendumtoquercitrinloadedcyclodextrinbasednanospongeasapromisingapproachformanagementoflungcancerandcovid19jdrugdelivscitechnol772022103921
AT asfourmarwahasanein corrigendumtoquercitrinloadedcyclodextrinbasednanospongeasapromisingapproachformanagementoflungcancerandcovid19jdrugdelivscitechnol772022103921

Ejemplares similares